200 related articles for article (PubMed ID: 8835491)
1. [Surgical therapy of ovarian carcinoma].
Sevelda P
Wien Med Wochenschr; 1996; 146(1-2):18-22. PubMed ID: 8835491
[TBL] [Abstract][Full Text] [Related]
2. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
Meier W; Römisch M; Hepp H
Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569
[TBL] [Abstract][Full Text] [Related]
3. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
4. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
[TBL] [Abstract][Full Text] [Related]
5. [Secondary debulking after dose-intensified chemotherapy of ovarian carcinoma].
Meier W; Gropp M; Burges A; Hepp H
Praxis (Bern 1994); 1999 Mar; 88(12):519-25. PubMed ID: 10235027
[TBL] [Abstract][Full Text] [Related]
6. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
8. Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy.
Landoni F; Pellegrino A; Cormio G; Milani R; Maggioni A; Mangioni C
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):233-7. PubMed ID: 9512334
[TBL] [Abstract][Full Text] [Related]
9. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
10. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Scarabelli C; Gallo A; Carbone A
Gynecol Oncol; 2001 Dec; 83(3):504-12. PubMed ID: 11733963
[TBL] [Abstract][Full Text] [Related]
11. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
Obermair A; Sevelda P
Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
[TBL] [Abstract][Full Text] [Related]
12. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
13. [The value of reoperation in the treatment of ovarian cancer].
Meier W; Römisch M; Hepp H
Geburtshilfe Frauenheilkd; 1993 Jan; 53(1):30-4. PubMed ID: 8440455
[TBL] [Abstract][Full Text] [Related]
14. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
[TBL] [Abstract][Full Text] [Related]
15. [The second-look operation in advanced ovarian cancer].
Richter P; Lotze W
Zentralbl Gynakol; 1987; 109(4):228-34. PubMed ID: 2438864
[TBL] [Abstract][Full Text] [Related]
16. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
[TBL] [Abstract][Full Text] [Related]
17. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
Friedman RL; Eisenkop SM; Wang HJ
Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
[TBL] [Abstract][Full Text] [Related]
19. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
20. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
